Lung cancer (LC) is the leading cause of cancer mortality, with more than 1 million deaths
worldwide every year. 1, 2 There are two major forms of LC disease: nonsmall cell LC …

A new non-invasive and potentially inexpensive frontier in the diagnosis of cancer relies on
the detection of volatile organic compounds (VOCs) in exhaled breath samples. Breath can …

The importance of developing new diagnostic and detection technologies for the growing
number of clinical challenges is rising each year. Here, we present a concise, yet didactic …

Volatile organic compounds (VOCs) are produced by virtually all metabolic processes of the
body. As such, they have potential to serve as noninvasive metabolic biomarkers. Since …

The detection of many diseases is missed because of delayed diagnoses or the low efficacy
of some treatments. This emphasizes the urgent need for inexpensive and minimally …

In this case study, we demonstrate the feasibility of nanomaterial-based sensors for
identifying the breath-print of early-stage lung cancer (LC) and for short-term follow-up after …

We report on a new concept for profiling genetic mutations of (lung) cancer cells, based on
the detection of patterns of volatile organic compounds (VOCs) emitted from cell …

Background Hepatocellular carcinoma (HCC) is a common and aggressive form of cancer.
Due to a high rate of postoperative recurrence, the prognosis for HCC is poor. Subclinical …

This paper describes the detection of volatile organic compounds (VOCs) using an e-nose
type integrated microfabricated sensor array, in which each resonator is coated with different …

Electronic-nose (e-nose) devices are instruments designed to detect and discriminate
between precise complex gaseous mixtures of volatile organic compounds derived from …